The KCNJ10 Gene SESAME Syndrome Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the KCNJ10 gene, which are associated with SESAME syndrome. SESAME syndrome, an acronym for Seizures, Sensorineural deafness, Ataxia, Mental retardation, and Electrolyte imbalance, is a rare genetic disorder. The KCNJ10 gene plays a critical role in the proper functioning of potassium channels in the brain, inner ear, and kidneys, and mutations in this gene can disrupt these processes, leading to the symptoms observed in SESAME syndrome.
This genetic test is crucial for early detection and management of the syndrome, offering insights into the specific genetic alterations present in an individual. With a test cost of 4400 AED, DNA Labs UAE utilizes advanced genetic sequencing technologies to provide accurate and reliable results. Early diagnosis through the KCNJ10 Gene SESAME Syndrome Genetic Test can significantly impact the management and treatment options for affected individuals, offering a path towards a better quality of life.
The SLC17A5 gene Sialuria Finnish Type genetic test is a specialized diagnostic tool designed to identify mutations in the SLC17A5 gene, which are responsible for causing Sialuria Finnish Type, a rare genetic disorder. This condition is characterized by an excess of free sialic acid in the body, leading to various symptoms such as developmental delay, coarse facial features, and organomegaly. The test involves analyzing the patient's DNA to detect mutations in the SLC17A5 gene, providing crucial information for diagnosis, management, and genetic counseling of affected individuals and their families.
Performed at DNA Labs UAE, a leading facility in genetic testing, the cost of the SLC17A5 gene Sialuria Finnish Type genetic test is 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced professionals, ensuring accurate and reliable test results. This test is an important resource for families with a history of Sialuria Finnish Type, offering them the opportunity for early diagnosis and intervention.
The GPC3 gene test for Simpson-Golabi-Behmel Syndrome Type 1 is a specialized genetic screening offered by DNA Labs UAE. This test is designed to identify mutations in the GPC3 gene, which are linked to the development of Simpson-Golabi-Behmel Syndrome Type 1 (SGBS1), a rare genetic disorder characterized by pre- and postnatal overgrowth, distinctive facial features, and a variety of organ abnormalities. The condition is primarily seen in males and can have variable expressivity. The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of specific genetic mutations associated with SGBS1.
The cost of the GPC3 gene test is 4400 AED, reflecting the specialized nature of the genetic analysis and the expertise required to interpret the results. Conducting the test at DNA Labs UAE ensures that patients receive accurate and reliable results, as the lab is equipped with state-of-the-art genetic testing technology and staffed by professionals with expertise in genetic disorders. This test is crucial for families seeking a diagnosis for symptoms consistent with Simpson-Golabi-Behmel Syndrome Type 1, as it provides essential information for managing the condition and understanding the risk of recurrence in future pregnancies.
The ALDH3A2 gene Sjogren-Larsson Syndrome genetic test is a diagnostic procedure offered by DNA Labs UAE, designed to detect mutations in the ALDH3A2 gene that are associated with Sjogren-Larsson Syndrome (SLS). Sjogren-Larsson Syndrome is a rare, inherited neurocutaneous disorder characterized by ichthyosis (scaly skin), intellectual disability, and spastic diplegia or quadriplegia. Mutations in the ALDH3A2 gene disrupt the metabolism of fatty alcohols, leading to the accumulation of toxic substances in the body, which in turn cause the symptoms of the syndrome.
This genetic test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of specific mutations in the ALDH3A2 gene that are known to cause SLS. Identifying these mutations can confirm a diagnosis of Sjogren-Larsson Syndrome, allowing for early intervention, management of symptoms, and genetic counseling for affected families.
The cost of the ALDH3A2 gene Sjogren-Larsson Syndrome genetic test at DNA Labs UAE is 4400 AED. This price may cover the test itself, the expertise of the medical professionals conducting and analyzing the test, and any post-test counseling that may be necessary based on the results. It's important for potential patients to check if additional costs may apply and if their insurance may cover part of the cost. The test provides crucial information for affected individuals and their families and represents a significant step in managing the condition effectively.
The RAI1 Gene Smith-Magenis Syndrome Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the RAI1 gene, which are associated with Smith-Magenis Syndrome (SMS). SMS is a developmental disorder characterized by distinctive facial features, developmental delay, behavioral problems, and sleep disturbances. The test plays a crucial role in the early detection and management of SMS, offering insights into potential interventions and support for affected individuals.
This genetic test involves analyzing the patient's DNA to look for specific alterations in the RAI1 gene that are known to cause Smith-Magenis Syndrome. Early diagnosis through this test can significantly benefit patients and families by providing them with a clear understanding of the condition, enabling access to targeted therapies, and support services, and facilitating informed decision-making regarding care and management.
At DNA Labs UAE, the RAI1 Gene Smith-Magenis Syndrome Genetic Test is priced at 4400 AED. This cost includes the collection of a DNA sample, usually through a blood draw or cheek swab, and its subsequent analysis in the laboratory. The price reflects the comprehensive nature of the test, encompassing the expertise required for accurate interpretation of the results and the provision of detailed genetic counseling to discuss the findings. This test represents a vital resource for families seeking answers about Smith-Magenis Syndrome, offering hope and direction in navigating the challenges associated with the disorder.
The "SACS Gene Spastic Ataxia Charlevoix-Saguenay Type Genetic Test" is a specialized diagnostic tool designed to identify mutations in the SACS gene, which is known to cause Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS). ARSACS is a neurodegenerative disorder characterized by a wide range of symptoms including ataxia, spasticity, and peripheral neuropathy, typically emerging in early childhood. This genetic test is crucial for confirming the diagnosis, enabling early intervention, and facilitating family planning decisions for those with a history of the disorder. Conducted by DNA Labs UAE, a leading facility in genetic diagnostics, the test is priced at 4400 AED. The process involves collecting a DNA sample, usually through a blood draw, and analyzing it for specific mutations in the SACS gene, providing valuable information for affected individuals and their families.
The VAMP1 Gene Spastic Ataxia Type 1 Autosomal Dominant Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the VAMP1 gene, which are associated with Spastic Ataxia Type 1, an autosomal dominant neurodegenerative disorder. This condition is characterized by a combination of spasticity and ataxia, leading to difficulties in movement and coordination. The test is crucial for individuals with a family history of the disorder or those exhibiting symptoms, as it can confirm the diagnosis and facilitate appropriate management and treatment plans. The cost of the test is 4400 AED, making it an accessible option for those seeking genetic testing services in the United Arab Emirates. By identifying the specific genetic mutation, healthcare providers can offer personalized care, potentially improving the quality of life for affected individuals and their families.
The "MARS2 Gene Spastic Ataxia Type 3 Autosomal Recessive Genetic Test" is a specialized diagnostic tool used to detect mutations in the MARS2 gene, which are linked to Spastic Ataxia Type 3, an autosomal recessive disorder. This condition is characterized by progressive difficulty with coordination and movement, as a result of damage to the part of the brain and spinal cord that controls voluntary movement. The test is vital for early diagnosis and management of the condition, allowing for tailored treatment plans and genetic counseling for affected families. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test costs 4400 AED. This state-of-the-art lab ensures accurate and reliable results, employing advanced genomic technologies to analyze the genetic material for any abnormalities associated with the disorder.
The "MTPAP Gene Spastic Ataxia Type 4 Autosomal Recessive Genetic Test" is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the MTPAP gene. These mutations are responsible for causing Spastic Ataxia Type 4, a rare autosomal recessive neurodegenerative disorder. This condition is characterized by a combination of spasticity and ataxia, affecting an individual's motor skills and coordination. The test is crucial for individuals with a family history of the disorder or presenting symptoms, as it provides definitive genetic evidence of the condition. The cost of the test is 4400 AED, making it a valuable investment for those seeking accurate diagnosis and subsequent management or genetic counseling based on the results.
The AFG3L2 gene plays a critical role in the proper functioning of the human nervous system. Mutations in this gene are associated with Spastic Ataxia Type 5, an autosomal recessive neurological disorder. This condition is characterized by a combination of spasticity and ataxia, which are, respectively, muscle stiffness and a lack of muscle control that leads to speech and movement difficulties. Due to its genetic basis, identifying carriers or affected individuals early can be crucial for management and counseling.
DNA Labs UAE offers a specialized genetic test targeting the AFG3L2 gene to identify mutations that may lead to Spastic Ataxia Type 5. This test is a vital tool for individuals with a family history of the condition or who are experiencing symptoms related to the disorder. The process involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the lab for specific mutations in the AFG3L2 gene.
The cost of the AFG3L2 gene test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of the information it provides for affected individuals and their families is immeasurable. It not only aids in the diagnosis of Spastic Ataxia Type 5 but also helps in making informed decisions regarding family planning and management of the disorder. With the test available at DNA Labs UAE, individuals have access to critical genetic information that can significantly impact their health management and quality of life.
